+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Transcriptomics Technologies Market by Technology Type, Experimental Method, Resolution Level, Data Output Type, Application - Global Forecast 2026-2032- Product Image
Transcriptomics Technologies Market by Technology Type, Experimental Method, Resolution Level, Data Output Type, Application - Global Forecast 2026-2032- Product Image
Sale

Transcriptomics Technologies Market by Technology Type, Experimental Method, Resolution Level, Data Output Type, Application - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 4985965
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Transcriptomics Technologies Market is projected to reach USD 8.79 Billion in 2026. It is expected to continue growing at a CAGR of 5.15%, reaching USD 11.93 Billion by 2032.

Transcriptomics technologies capture RNA expression, isoform diversity, gene regulation, and cellular state, making them central to modern genomics, precision medicine, drug discovery, biomarker development, and translational research. The field is anchored by bulk RNA sequencing, single-cell RNA sequencing, single-nucleus RNA sequencing, spatial transcriptomics, microarrays, qPCR-based expression profiling, and long-read RNA sequencing, each serving distinct research and clinical workflows.

Demand is rising as pharmaceutical sponsors, academic medical centers, contract research organizations, and diagnostic developers use transcriptome data to understand disease mechanisms, stratify patients, monitor therapeutic response, and identify actionable pathways. Public repositories such as the NCBI Gene Expression Omnibus, Sequence Read Archive, and European Nucleotide Archive continue to expand with transcriptomic datasets, reflecting the growing scale of RNA-based research across oncology, immunology, neuroscience, infectious disease, reproductive health, and agricultural biotechnology.

Transformative Shifts in the Transcriptomics Landscape

The transcriptomics landscape is shifting from single-assay gene expression measurement toward integrated, multi-omic, spatially resolved, and AI-supported biological interpretation. Bulk RNA sequencing remains a cost-effective discovery tool, while single-cell and single-nucleus methods are transforming cell-type resolution in complex tissues, particularly in cancer, brain science, autoimmune disease, and developmental biology.

Spatial transcriptomics is one of the most important accelerators because it preserves tissue architecture while mapping gene expression, supporting pathology-adjacent research and translational oncology. At the same time, automation, unique molecular identifiers, improved sample preparation, cloud bioinformatics, and standardized quality-control metrics are reducing technical variability and improving scalability for regulated and high-throughput environments.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is compounding the value of transcriptomics by improving data normalization, cell annotation, batch correction, trajectory inference, spatial deconvolution, biomarker prioritization, and drug target discovery. Machine learning and deep learning models are especially useful for extracting patterns from high-dimensional RNA sequencing data that are difficult to detect with conventional statistics alone.

The cumulative impact of AI is most visible when transcriptomics is integrated with genomics, proteomics, epigenomics, imaging, clinical records, and real-world evidence. However, industry leaders must manage model bias, explainability, data provenance, privacy protection, and reproducibility. AI-enabled transcriptomics will create the greatest value where curated datasets, transparent pipelines, and clinically interpretable outputs are aligned with regulatory expectations and documented quality standards.

Key Regional Insights

Asia-Pacific is expanding rapidly as China, Japan, India, South Korea, and Australia invest in genomics infrastructure, academic sequencing centers, biopharmaceutical R&D, and population-scale biomedical initiatives. Regional adoption is supported by cancer genomics programs, infectious disease surveillance, aging-related research, and agriculture biotechnology applications. North America remains a global leader due to strong public biomedical funding, major biotechnology clusters, advanced sequencing adoption, and a dense ecosystem of instrument suppliers, cloud providers, contract research organizations, clinical laboratories, and precision medicine programs.

Europe benefits from coordinated research frameworks, biobanks, national health systems, and regulatory emphasis on data protection, reproducibility, and clinical evidence, with transcriptomics increasingly applied in oncology, rare disease, immunology, and population health research. Latin America is gaining momentum through infectious disease research, oncology collaborations, and expanding university-based sequencing capacity, especially in Brazil and Mexico. The Middle East is increasing investment in genomics-led healthcare and national precision medicine programs, particularly in Gulf markets, where rare disease, inherited disorder, and cancer initiatives are relevant. Africa is strengthening transcriptomics capabilities through infectious disease research, pathogen surveillance, population genetics, and international research partnerships that improve local sequencing, bioinformatics, and sample-to-data workflows.

Key Group Insights

ASEAN is becoming more relevant for transcriptomics through biomedical research growth in Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines, supported by regional disease surveillance, cancer research, population health studies, and agricultural biotechnology. The GCC is prioritizing genomics as part of healthcare modernization, with transcriptomics positioned to support rare disease research, cancer profiling, inherited disease investigation, and national population health initiatives.

The European Union supports transcriptomics through collaborative research funding, harmonized clinical research networks, cross-border biobanking, and strict data-governance requirements under GDPR, strengthening demand for secure and reproducible data pipelines. BRICS economies contribute scale through large patient populations, expanding pharmaceutical services, biomanufacturing capacity, infectious disease research, and national genomics programs, while the G7 leads in advanced sequencing infrastructure, AI-enabled life sciences, regulatory science, and clinical translation. NATO-aligned countries also support biosecurity, pathogen monitoring, health security, and defense-adjacent biotechnology capabilities that can include transcriptomic surveillance and rapid-response molecular research.

Key Country Insights

The United States leads transcriptomics commercialization through biotechnology clusters, academic medical centers, pharmaceutical R&D, national biomedical research funding, clinical genomics programs, and a mature venture capital environment, while Canada supports strong genomics research through national networks, population health initiatives, and precision health programs. Mexico and Brazil are expanding capabilities in oncology, infectious disease, and agricultural biotechnology, with Brazil benefiting from a large biomedical research base, public health research capacity, and biodiversity-driven applications.

In Europe, the United Kingdom, Germany, and France are major centers for genomics research, clinical trials, biobanking, molecular pathology, and translational medicine, while Italy and Spain contribute through hospital-based research, oncology networks, and EU-supported life science programs. Russia maintains scientific capability in molecular biology and bioinformatics, though international collaboration dynamics can affect access to advanced technologies, reagents, and commercialization pathways.

China is a scale leader in sequencing, clinical research, and biomanufacturing, supported by major investment in genomics infrastructure and precision medicine. India is rapidly expanding genomics adoption across healthcare, pharmaceutical services, bioinformatics, and infectious disease research. Japan emphasizes high-quality clinical research, aging-related disease studies, regenerative medicine, and oncology applications. Australia contributes through population health, cancer genomics, rare disease programs, and research consortia, and South Korea is advancing precision medicine through strong digital health, biopharma, clinical research, and sequencing infrastructure.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize platforms that connect sample preparation, sequencing, bioinformatics, and interpretation in reproducible, auditable workflows. Investment decisions should favor technologies that improve sensitivity, throughput, spatial resolution, transcript isoform detection, and compatibility with degraded or low-input samples, especially formalin-fixed paraffin-embedded tissue used in translational oncology and pathology-linked research.

Organizations should build AI governance into product development, including dataset documentation, model validation, auditability, bias monitoring, privacy safeguards, and human-in-the-loop review. Partnerships with hospitals, biobanks, pharmaceutical sponsors, cloud infrastructure providers, regulatory experts, and academic consortia can accelerate clinical evidence generation, while workforce training in computational biology, molecular pathology, bioinformatics, and data engineering will remain essential for scalable adoption.

Research Methodology

The research methodology applies a triangulated approach combining peer-reviewed scientific literature, public genomic data repositories, clinical trial registries, regulatory guidance, funding announcements, patent activity, public health resources, and technology adoption indicators. The analysis emphasizes verified evidence from recognized scientific, regulatory, and institutional sources rather than unsupported commercial claims.

Segmentation is assessed across technology type, workflow, application, end user, and geography. Findings are validated through consistency checks across scientific adoption trends, translational research activity, regulatory developments, infrastructure availability, and regional research capacity, ensuring that conclusions reflect observable transcriptomics technology dynamics without relying on market sizing, share estimates, or forecasts.

Conclusion

Transcriptomics technologies are moving from exploratory research tools to foundational infrastructure for precision medicine, drug discovery, molecular diagnostics, and biological systems analysis. Momentum is supported by lower sequencing barriers, rising use of single-cell and spatial methods, improved long-read RNA analysis, stronger cloud bioinformatics, and demand for clinically meaningful RNA-based biomarkers.

The next phase of competition will be defined by integrated workflows, AI-enabled interpretation, data quality, regulatory readiness, interoperability, and regional access to advanced sequencing capabilities. Organizations that combine scientific rigor with scalable operations, transparent analytics, and clinically relevant evidence will be best positioned to capture value in the global transcriptomics technologies landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Transcriptomics Technologies Market, by Technology Type
7.1. Bulk Transcriptomics
7.2. Single-Cell Transcriptomics
7.3. Spatial Transcriptomics
7.4. Spatially Resolved Single-Cell Technologies
8. Transcriptomics Technologies Market, by Experimental Method
8.1. Sequencing-Based Technologies
8.2. Probe-Based Technologies
8.3. Imaging-Based Technologies
8.4. Array-Based Technologies
9. Transcriptomics Technologies Market, by Resolution Level
9.1. Bulk Resolution
9.2. Single-Cell Resolution
9.3. Subcellular Resolution
10. Transcriptomics Technologies Market, by Data Output Type
10.1. Whole Transcriptome Profiling
10.2. Targeted Transcriptomics
10.3. Multi-Omics Integrated Transcriptomics
11. Transcriptomics Technologies Market, by Application
11.1. Oncology
11.2. Neurology
11.3. Immunology
11.4. Developmental Biology
11.5. Drug Discovery
12. Asia-Pacific Transcriptomics Technologies Market
13. North America Transcriptomics Technologies Market
14. Latin America Transcriptomics Technologies Market
15. Europe Transcriptomics Technologies Market
16. Middle East Transcriptomics Technologies Market
17. Africa Transcriptomics Technologies Market
18. ASEAN Transcriptomics Technologies Market
19. GCC Transcriptomics Technologies Market
20. European Union Transcriptomics Technologies Market
21. BRICS Transcriptomics Technologies Market
22. G7 Transcriptomics Technologies Market
23. NATO Transcriptomics Technologies Market
24. United States Transcriptomics Technologies Market
25. Canada Transcriptomics Technologies Market
26. Mexico Transcriptomics Technologies Market
27. Brazil Transcriptomics Technologies Market
28. United Kingdom Transcriptomics Technologies Market
29. Germany Transcriptomics Technologies Market
30. France Transcriptomics Technologies Market
31. Russia Transcriptomics Technologies Market
32. Italy Transcriptomics Technologies Market
33. Spain Transcriptomics Technologies Market
34. China Transcriptomics Technologies Market
35. India Transcriptomics Technologies Market
36. Japan Transcriptomics Technologies Market
37. Australia Transcriptomics Technologies Market
38. South Korea Transcriptomics Technologies Market
39. Competitive Landscape
39.1. Market Concentration Analysis, 2025
39.1.1. Concentration Ratio (CR)
39.1.2. Herfindahl Hirschman Index (HHI)
39.2. Recent Developments & Impact Analysis, 2025
39.3. Product Portfolio Analysis, 2025
39.4. Benchmarking Analysis, 2025
40. Company Profiles
40.1. 10x Genomics
40.2. Agilent Technologies, Inc.
40.3. Akoya Biosciences, Inc.
40.4. BGI Genomics Co., Ltd.
40.5. Bio-Rad Laboratories, Inc.
40.6. Bio-Techne Corporation
40.7. Dovetail Genomics
40.8. F. Hoffmann-La Roche Ltd.
40.9. Genomics England ecosystem partners
40.10. Illumina, Inc.
40.11. Mission Bio Inc.
40.12. NanoString Technologies
40.13. Novogene Corporation
40.14. Oxford Nanopore Technologies plc
40.15. Pacific Biosciences of California, Inc.
40.16. Parse Biosciences
40.17. QIAGEN N.V.
40.18. SeqWell Inc.
40.19. Singleron Biotechnologies
40.20. Standard BioTools Inc.
40.21. Takara Bio Inc.
40.22. Thermo Fisher Scientific Inc.
40.23. Ultivue Inc.
40.24. Vizgen Inc.
List of Figures
FIGURE 1. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2025 VS 2032 (%)
FIGURE 17. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2025 VS 2032 (%)
FIGURE 19. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2025 VS 2032 (%)
FIGURE 21. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. NORTH AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. NORTH AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. LATIN AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. LATIN AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. EUROPE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. EUROPE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. MIDDLE EAST TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. MIDDLE EAST TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. AFRICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. AFRICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. ASEAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. ASEAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. GCC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. GCC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. EUROPEAN UNION TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. EUROPEAN UNION TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. BRICS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. BRICS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. G7 TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. G7 TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. NATO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. NATO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. UNITED KINGDOM TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. GERMANY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. FRANCE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. RUSSIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. ITALY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. SPAIN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. JAPAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. SOUTH KOREA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BULK TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BULK TRANSCRIPTOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BULK TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL SINGLE-CELL TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL SINGLE-CELL TRANSCRIPTOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL SINGLE-CELL TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL SPATIAL TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL SPATIAL TRANSCRIPTOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL SPATIAL TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL SPATIALLY RESOLVED SINGLE-CELL TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL SPATIALLY RESOLVED SINGLE-CELL TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL SPATIALLY RESOLVED SINGLE-CELL TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL SEQUENCING-BASED TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL SEQUENCING-BASED TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL SEQUENCING-BASED TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PROBE-BASED TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PROBE-BASED TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PROBE-BASED TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL IMAGING-BASED TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL IMAGING-BASED TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL IMAGING-BASED TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ARRAY-BASED TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ARRAY-BASED TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ARRAY-BASED TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BULK RESOLUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BULK RESOLUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BULK RESOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL SINGLE-CELL RESOLUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL SINGLE-CELL RESOLUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL SINGLE-CELL RESOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL SUBCELLULAR RESOLUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL SUBCELLULAR RESOLUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL SUBCELLULAR RESOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL WHOLE TRANSCRIPTOME PROFILING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL WHOLE TRANSCRIPTOME PROFILING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL WHOLE TRANSCRIPTOME PROFILING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL TARGETED TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL TARGETED TRANSCRIPTOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL TARGETED TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL MULTI-OMICS INTEGRATED TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL MULTI-OMICS INTEGRATED TRANSCRIPTOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL MULTI-OMICS INTEGRATED TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL IMMUNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL IMMUNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL DEVELOPMENTAL BIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL DEVELOPMENTAL BIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL DEVELOPMENTAL BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL DRUG DISCOVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 72. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 73. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 74. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 75. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. NORTH AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 78. NORTH AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 82. LATIN AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. LATIN AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 84. LATIN AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 85. LATIN AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 88. EUROPE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. EUROPE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 90. EUROPE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 91. EUROPE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 92. EUROPE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 93. EUROPE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 94. MIDDLE EAST TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. MIDDLE EAST TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 96. MIDDLE EAST TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 97. MIDDLE EAST TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 98. MIDDLE EAST TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 99. MIDDLE EAST TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 100. AFRICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. AFRICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 102. AFRICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 103. AFRICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 104. AFRICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 105. AFRICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 106. ASEAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. ASEAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 108. ASEAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 109. ASEAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 110. ASEAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 111. ASEAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 112. GCC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GCC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 114. GCC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 115. GCC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 116. GCC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 117. GCC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 118. EUROPEAN UNION TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. EUROPEAN UNION TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 120. EUROPEAN UNION TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 121. EUROPEAN UNION TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 122. EUROPEAN UNION TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 123. EUROPEAN UNION TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 124. BRICS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. BRICS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 126. BRICS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 127. BRICS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 128. BRICS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 129. BRICS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 130. G7 TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. G7 TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 132. G7 TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 133. G7 TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 134. G7 TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 135. G7 TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 136. NATO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 137. NATO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 138. NATO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 139. NATO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 140. NATO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 141. NATO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 142. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 143. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 144. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 145. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 146. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 147. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 148. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 149. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 150. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 151. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 152. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 153. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 154. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 155. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 156. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 157. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 158. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 159. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 161. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 162. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 163. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 164. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 165. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 166. UNITED KINGDOM TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 167. UNITED KINGDOM TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 168. UNITED KINGDOM TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 169. UNITED KINGDOM TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 170. UNITED KINGDOM TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 171. UNITED KINGDOM TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 172. GERMANY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 173. GERMANY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 174. GERMANY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 175. GERMANY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 176. GERMANY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 177. GERMANY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. FRANCE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 179. FRANCE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 180. FRANCE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 181. FRANCE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 182. FRANCE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 183. FRANCE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 184. RUSSIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 185. RUSSIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 186. RUSSIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 187. RUSSIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 188. RUSSIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 189. RUSSIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 190. ITALY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 191. ITALY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 192. ITALY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 193. ITALY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 194. ITALY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 195. ITALY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 196. SPAIN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 197. SPAIN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 198. SPAIN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 199. SPAIN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 200. SPAIN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 201. SPAIN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 202. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 203. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 204. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 205. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 206. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 207. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 208. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 209. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 210. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 211. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 212. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 213. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 214. JAPAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 215. JAPAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 216. JAPAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 217. JAPAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 218. JAPAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 219. JAPAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 220. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 221. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 222. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 223. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 224. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 225. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 226. SOUTH KOREA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 227. SOUTH KOREA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 228. SOUTH KOREA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
TABLE 229. SOUTH KOREA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
TABLE 230. SOUTH KOREA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
TABLE 231. SOUTH KOREA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Transcriptomics Technologies market report include:
  • 10x Genomics
  • Agilent Technologies, Inc.
  • Akoya Biosciences, Inc.
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Dovetail Genomics
  • F. Hoffmann-La Roche Ltd.
  • Genomics England ecosystem partners
  • Illumina, Inc.
  • Mission Bio Inc.
  • NanoString Technologies
  • Novogene Corporation
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California, Inc.
  • Parse Biosciences
  • QIAGEN N.V.
  • SeqWell Inc.
  • Singleron Biotechnologies
  • Standard BioTools Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Ultivue Inc.
  • Vizgen Inc.

Table Information

Report AttributeDetails
No. of Pages186
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 8.79 Billion
Forecasted Market Value ( USD ) by 2032 $ 11.93 Billion
Compound Annual Growth Rate5.1%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

RNA Analysis/Transcriptomics Market - Global Forecast 2026-2032 - Product Image

RNA Analysis/Transcriptomics Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Spatial Genomics & Transcriptomics Market - Global Forecast 2026-2032 - Product Image

Spatial Genomics & Transcriptomics Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Transcriptomics Market Size, Share, Trends and Forecast by Type, Technology, Application, End User, and Region, 2026-2034 - Product Image

Transcriptomics Market Size, Share, Trends and Forecast by Type, Technology, Application, End User, and Region, 2026-2034

  • Report
  • 150 Pages
  • Global
From
Spatial Genomics and Transcriptomics Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Spatial Genomics and Transcriptomics Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Spatial Transcriptomics Market Size, Share & Trends Analysis Report by Products, Technology, Workflow, Sample Type, End Use, and Region with Growth Forecasts, 2025-2033 - Product Image

Spatial Transcriptomics Market Size, Share & Trends Analysis Report by Products, Technology, Workflow, Sample Type, End Use, and Region with Growth Forecasts, 2025-2033

  • Report
  • 120 Pages
  • Global
From

About the Transcriptomics Market

The Transcriptomics market is a segment of the biotechnology industry that focuses on the study of gene expression. It involves the analysis of the transcriptome, which is the set of all RNA molecules in a cell. This includes mRNA, tRNA, and rRNA. Transcriptomics is used to study gene expression, regulation, and function. It is used to identify and characterize genes, as well as to understand the role of genes in disease and development. Transcriptomics can also be used to identify biomarkers for diagnosis and prognosis, and to develop new therapeutic targets. Some companies in the Transcriptomics market include Illumina, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, and QIAGEN. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.